Werewolf Therapeutics, Inc. (HOWL): Price and Financial Metrics

Werewolf Therapeutics, Inc. (HOWL): $1.64

0.03 (-1.80%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add HOWL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#119 of 332

in industry

HOWL Price/Volume Stats

Current price $1.64 52-week high $8.19
Prev. close $1.67 52-week low $1.58
Day low $1.59 Volume 481,900
Day high $1.67 Avg. volume 380,052
50-day MA $2.24 Dividend yield N/A
200-day MA $3.83 Market Cap 73.08M

HOWL Stock Price Chart Interactive Chart >


Werewolf Therapeutics, Inc. (HOWL) Company Bio


Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It offers PREDATOR, a platform of protein engineering technology to design and engineer the future of immuno-oncology biotherapeutics for patients. The company's lead product candidates include WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. It also develops WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.


HOWL Latest News Stream


Event/Time News Detail
Loading, please wait...

HOWL Latest Social Stream


Loading social stream, please wait...

View Full HOWL Social Stream

HOWL Price Returns

1-mo -54.82%
3-mo -31.38%
6-mo -66.39%
1-year -31.09%
3-year -89.59%
5-year N/A
YTD -57.51%
2023 88.29%
2022 -82.79%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!